AZD5153 in Patients With Relapsed or Refractory Solid Tumors, Including Lymphomas

Clinical trial NCT03205176 · COMPLETED

Trial details

NCT number: NCT03205176
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Solid Tumors Lymphoma Ovarian Cancer Breast Cancer Pancreatic Cancer Prostate Cancer

Start date: 2017-06-30
Primary completion: 2021-03-01
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.